Patents by Inventor Robert Arslanian

Robert Arslanian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations
    Patent number: 7648976
    Abstract: Polymorphs and pharmaceutical formulations of 17-allylamino-17-demethoxygeldanamycin (17-AAG).
    Type: Grant
    Filed: November 8, 2006
    Date of Patent: January 19, 2010
    Assignee: Bristol-Myers Squibb Company
    Inventors: Peter J. Licari, Timothy Leaf, Ruchir P. Desai, Jorge L. Galazzo, Greg O. Buchanan, Stephen William Watt, Alexander Redvers Eberlin, Robert Arslanian
  • 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN POLYMORPHS AND FORMULATIONS
    Publication number: 20090042847
    Abstract: Polymorphs and pharmaceutical formulations of 17-allylamino-17-demethoxy-geldanamycin (17-AAG).
    Type: Application
    Filed: May 29, 2008
    Publication date: February 12, 2009
    Applicant: Kosan Biosciences Incorporated
    Inventors: Peter J. Licari, Timothy Leaf, Ruchir P. Desai, Jorge L. Galazzo, Greg O. Buchanan, Stephen William Watt, Alexander Redvers Eberlin, Robert Arslanian
  • PRODUCTION OF POLYKETIDES
    Publication number: 20070281343
    Abstract: Recombinant Myxococcus host cells can be used to produce polyketides, including epothilone and epothilone analogs that can be purified from the fermentation broth and crystallized.
    Type: Application
    Filed: August 8, 2005
    Publication date: December 6, 2007
    Inventor: Robert Arslanian
  • 17-Allylamino-17-demethoxygeldanamycin polymorphs and formulations
    Publication number: 20070203110
    Abstract: Polymorphs and pharmaceutical formulations of 17-allylamino-17-demethoxygeldanamycin (17-AAG).
    Type: Application
    Filed: November 8, 2006
    Publication date: August 30, 2007
    Inventors: Peter Licari, Timothy Leaf, Ruchir Desai, Jorge Galazzo, Greg Buchanan, Stephen Watt, Alexander Eberlin, Robert Arslanian
  • Production of polyketides
    Publication number: 20070092954
    Abstract: Recombinant Myxococcus host cells can be used to produce polyketides, including epothilone and epothilone analogs that can be purified from the fermentation broth and crystallized.
    Type: Application
    Filed: August 8, 2005
    Publication date: April 26, 2007
    Inventors: Robert Arslanian, Gary Ashley, Scott Frykman, Bryan Julien, Leonard Katz, Chaitan Khosla, Janice Lau, Peter Licari, Rika Regentin, Daniel Santi, Li Tang
  • Epothilone derivatives and methods for making and using the same
    Publication number: 20050038086
    Abstract: This invention relates to compounds of formula (I) and to pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R5, W, X, Y, and Ar are as defined herein. Compounds of formula (I) are useful in the treatment of diseases or conditions characterized by cellular hyperproliferation. This invention also relates to means for the preparation of compounds of formula (I); formulations containing compounds of formula (I); and methods for the use of said compounds and formulations in the treatment of a disease or condition characterized by cellular hyperproliferation, including cancer.
    Type: Application
    Filed: May 12, 2004
    Publication date: February 17, 2005
    Inventors: Gary Ashley, Robert Arslanian, John Carney, Brian Metcalf, Li Tang
  • Fermentation and purification of mycolactones
    Publication number: 20040067563
    Abstract: Fermentation based methods for producing mycolactones allows one to produce large quantities of mycolactones, which can be purified by extraction and chromatography to yield pure preparations of mycolactones A, B, C, and D.
    Type: Application
    Filed: May 7, 2003
    Publication date: April 8, 2004
    Inventors: Robert Arslanian, John Carney
  • Fermentation and purification of mycolactones
    Patent number: 6562602
    Abstract: Fermentation based methods for producing mycolactones allows one to produce large quantities of mycolactones, which can be purified by extraction and chromatography to yield pure preparations of mycolactones A, B, C, and D.
    Type: Grant
    Filed: August 3, 2001
    Date of Patent: May 13, 2003
    Assignee: Kosan Biosciences, Inc.
    Inventors: Peter Licari, Robert Arslanian, Lawrence Cadapan, John Carney
  • Fermentation and purification of mycolactones
    Publication number: 20020086375
    Abstract: Fermentation based methods for producing mycolactones allows one to produce large quantities of mycolactones, which can be purified by extraction and chromatography to yield pure preparations of mycolactones A, B, C, and D.
    Type: Application
    Filed: August 3, 2001
    Publication date: July 4, 2002
    Inventors: Peter Licari, Robert Arslanian, Lawrence Cadapan, John Carney
  • High purity beta-carotene and process for obtaining same
    Publication number: 20020082459
    Abstract: The process of the present invention relates to the isolation and purification of both a natural mixed carotenoid product and an all-trans-&bgr;-carotene product from various different biomass sources, preferably from algae of the genus Dunaliella. More particularly, the present invention relates to a single solvent process whereby both natural and colorant products lie along the same process line. The nutritional product contains the natural array of carotenes and xanthophylls found in the plant material, while the colorant product contains primarily trans-&bgr;-carotene.
    Type: Application
    Filed: November 16, 2001
    Publication date: June 27, 2002
    Inventors: David T. Bailey, Randall J. Daughenbaugh, Robert Arslanian, Leonard A. Kaufmann, Steven L. Richheimer, Zhengjie Z. Liu, James M. Piffarerio, Chris J. Kurtz